|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.304 SEK | -5.00% |
|
+15.15% | -25.49% |
AlphaHelix Molecular Diagnostics AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 6.1 million compared to SEK 9.96 million a year ago. Revenue was SEK 6.33 million compared to SEK 10.03 million a year ago.
Net loss was SEK 4.26 million compared to SEK 0.034 million a year ago. Basic loss per share from continuing operations was SEK 0.07.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.49% | 1.8M | |
| +11.91% | 227B | |
| +15.46% | 198B | |
| +18.58% | 142B | |
| +30.36% | 111B | |
| +0.23% | 64.16B | |
| +17.74% | 54.1B | |
| +5.82% | 51.41B | |
| +11.23% | 45.32B | |
| +5.73% | 37.32B |
ALPHAHELIX MOLECULAR DIAGNOSTICS AB 
